150 Logo 4357 Pill - beige round, 9mm
Pill with imprint 150 Logo 4357 is Beige, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.
Ranitidine is used in the treatment of GERD; Gastric Ulcer Maintenance Treatment; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Cutaneous Mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 150 Logo 4357
Ranitidine Hydrochloride
- Imprint
- 150 Logo 4357
- Strength
- 150 mg
- Color
- Beige
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00172-4357 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
hypromelloses,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
titanium dioxide,
triethyl citrate,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
- Ranitidine drug information
- Ranitidine Tablets and Capsules
- Ranitidine Injection
- Ranitidine Suspension
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
